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Abstract
Purpose Lymphedema is a chronic and disabling sequel of
breast cancer treatment that can be treated by lymphatico-
venous anastomosis (LVA). Artificial connections between
the venous and lymphatic system are performed supermi-
crosurgically. This prospective study analyses the effect of
LVA on quality of life.
Methods A prospective study was performed between
November 2015 and July 2016 on consecutive patients in
the Maastricht University Medical Centre. Quality of life
was considered as the primary outcome, and the Lym-
phedema International Classification of Functioning
(Lymph-ICF) questionnaire was used. Discontinuation of
compressive stockings and arm volume, using the Upper
Extremity Lymphedema index (UEL-index), were the
secondary outcomes.
Results Twenty women with early-stage breast cancer-re-
lated lymphedema (BCRL) were included. The mean age
was 55.9 ± 4 years and the median BMI was 25.1 [21–30]
kg/m2. The mean follow-up was 7.8 ± 1.5 months. Sta-
tistically significant improvement in quality of life was
achieved in the total score and for all the quality of life
domains after one year of follow-up (p\ 0.05). The dis-
continuation rate in compressive stockings use was 85%.
The difference in mean relative volume did not show a
statistically significant decrease.
Conclusions LVA for early-stage BCRL resulted in a
significant improvement in quality of life and a high rate in
stocking discontinuation.
Keywords Breast cancer  Lymphedema  Quality of life 
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Purpose
Lymphedema is a debilitating disease with a profound
adverse effect on quality of life [1]. Breast cancer-related
lymphedema (BCRL) is caused by an acquired interruption
of lymphatic drainage after loco regional treatment such as
radiotherapy and/or lymph node dissection [2–5]. Since
breast cancer survival rates have risen over the past dec-
ades, there is an increasing demand by patients to focus on
the improvement of quality of life after breast cancer [6, 7].
Therefore, the search for effective treatments in BCRL has
gained popularity.
Standard therapy for lymphedema remains ‘complex
decongestive therapy’, which aims to ameliorate the
symptoms and delay progression of this chronic disease
[8, 9]. However, for most patients a lifelong, complex
decongestive therapy might be necessary.
Supermicrosurgical techniques, such as lymphatico-ve-
nous anastomosis (LVA), have been used with satisfactory
results since the introduction of this technique by Koshima
in the late ‘90 s [10–13]. By means of an LVA, an artificial
connection is created between a patent lymphatic collector
and a subdermal vein in a lymphoedematous limb. This
principle is based on the existence of physiological
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anatomic connections between the lymphatic and the
venous system [14–17].
Recent advances in techniques, such as the indocyanine
green (ICG) fluorescence lymphangiography, more precise
microscopes and optimal patient selection have resulted in
less invasive and faster LVA procedures, allowing LVA to
be performed under local anaesthesia with a substantially
reduced operating time [18–22].
In previous studies, reduction in volume was mostly
named as the primary outcome after lymphedema treatment
[10–13]. Yet an improvement in quality of life should be
considered as the ultimate aim in treating BCRL patients.
Therefore, this current prospective study evaluates the
effect of LVA on the quality of life of patients with BCRL.
Methods
Patient selection
A prospective study was performed, including consecutive
patients between November 2015 and July 2016 in the
Maastricht University Medical Centre. Inclusion criteria
consisted of an evidenced upper limb lymphedema sec-
ondary to breast cancer in stage 1 or 2A according to the
International Society of Lymphology (ISL) classification
[23], patent lymphatic ducts seen by ICG lymphangiogra-
phy and an absence of skin infections and complex
decongestive therapy for at least 3 months.
Demographic data and other factors that might influence
lymphedema such as chemotherapy, radiotherapy, lymph
node dissection and previous skin infections, were docu-
mented. Complications secondary to the surgery were
registered.
ICG lymphangiography
Preoperatively, all patients underwent ICG lymphangiog-
raphy to determine whether patent lymphatic ducts could
be tracked. ICG 0.5%, 0.05 ml (PULSION 25 mg for
solution, PULSION Medical Systems SE, Feldkirchen,
Germany) was subcutaneously injected in the second and
fourth web spaces. After 15–30 min, the fluorescence was
detected using a near infrared camera (Fluobeam; Flu-
optics, Grenoble France).
Surgical technique
The operation was performed (SQ and RH) using the
technique described by Koshima et al. [24] under local
anaesthesia (bupivacaine hydrochloride 5 mg/ml with
adrenaline 5lg/ml). In brief, the lymphatic ducts were
located and an anastomosis was made with a subcutaneous
vein using Ethilon 11-0. Patency was checked intraopera-
tively by distal injection of methylene blue in all cases, and
when possible, by ICG lymphangiography after finishing
the anastomosis. Patients were told not to use stockings or
conservative treatment in the first month after surgery to
prevent damage of the fragile, newly performed
anastomosis.
Outcomes
Quality of life was considered as the primary outcome,
measured by the Lymphedema international classification
of functioning (Lymph-ICF) questionnaire (Dutch version)
[25]. This questionnaire comprises five domains: physical
function, mental function, household activities, mobility
activities and life and social activities. The values range
from 1 to 100; a lower score on the questionnaire indicates
a better quality of life. Patients were asked to fill in the
questionnaires at 1, 3, 6 and 12 months postoperatively
with a time window of 4 weeks. A decrease in the VAS
score of more than 11, and an increase of more than 9 are
considered to be statistically significant (p\ 0.05) as val-
idated previously [25].
Secondary outcomes were the use of compressive
stockings and arm volume changes according to the Upper
Extremity Lymphedema index (UEL-index) [26]. Mea-
surements were obtained preoperatively and at 1, 3, 6 and
12 months postoperatively by the same independent
researcher (AC) to prevent inter-observer bias.
Statistical analysis
Continuous variables were reported as mean with standard
deviation or median with range, depending on the nor-
mality tested by the Kolmogorov–Smirnov test. Categori-
cal data were reported as frequencies and proportions.
Statistically significant differences in mean between groups
were tested using a paired two-tailed t test. A
p value\ 0.05 was considered to be statistically signifi-
cant. Results were analysed using SPSS Statistics 24.
Results
Study characteristics
A total of 20 patients with BCRL were included. Stage 1
according to ISL was present in one patient, whereas stage
2A was seen in the rest of the patients. All these patients
were female with a mean age of 55.9 ± 4 years and a
median BMI of 25.1 [21–33] kg/m2. The median time since
the onset of arm lymphedema was 6 [2–30] years and 25%
of the patients had experienced at least one episode of skin
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infection since the diagnosis of lymphedema. The mean
follow-up time was 7.8 ± 1.5 months. Information on
main study charactersitcs are shown in Table 1.
The average operating timewas 92 ± 8 min. The number
of anastomoses per patient varied between one and two, and
no statistically significant difference was found. Minor
complications were observed postoperatively in two cases
due to skin irritation at the site of the contrast injection. These
complications were resolved with a conservative approach.
Outcomes
Regarding quality of life, all the domains and the total score
of the Lymph-ICF showed improvement postoperatively. In
comparison with the preoperative results, statistical signifi-
cance was encountered for all the domains and the total score
after one year of follow-up (p\ 0.05). (Figure 1)
The discontinuation of compressive stocking use was
achieved in 85% (n = 17) of patients.
The mean relative volume difference in UEL between a
healthy and lymphoedematous arm preoperatively was
14.92 ± 8.01 and postoperatively 12.99 ± 7.47.However, the
difference did not reach statistical significance (p = 0.582).
Discussion
Lymphedema might be considered as one of the main
complications of breast cancer treatment, with a crucial
impact on the quality of life of breast cancer survivors.
Therefore, the main goal in treating lymphedema patients
should be an improvement in their quality of life. In the
current prospective study, according to the pre- and post-
operative QOL questionnaires, a substantial improvement
was achieved after performing LVA procedures within the
first-year follow-up.
It was remarkable that the total score, obtained via the
questionnaires, showed a statistically significant difference,
suggesting that through this surgical procedure, quality of
life can be improved. The current study reported a statis-
tically significant QOL improvement in 90% of the cases.
In those patients with no significant difference, the pre-
operative scores were low, which might indicate that the
lymphedema, even though clinically evident, did not have a
relevant impact on their quality of life. However, in none of
the cases did the total score of quality of life deteriorate
after surgery. The physical function presented a statistically
significant improvement after surgery. This domain eval-
uates the ‘classic’ lymphedema symptoms like pain, stiff-
ness, swelling, loss of strength, tingling and tenseness. The
majority of patients stated that a less disagreeable feeling
was experienced in their arm postoperatively, mainly due
to less heaviness and partially because of the discontinua-
tion of compressive stockings. The improvement in phys-
ical symptoms could have led to a betterment in mobility,
household activities and life and social activities. These
three domains improved statistically and significantly only
after 6 and/or 12 months, but not immediately after the
surgery. Significant differences were also present in the
mental function of the patients after surgery. As mentioned
before, the use of stockings was considered as one of the
patients’ predominant complaints. Without stockings, the
lymphedema may become less obvious to the patients’
surroundings, thus enhancing their self-confidence and
self-control about the disease.
Previous studies achieved similar percentages in the sub-
jective symptoms after LVA (61.5–100%) [11–13, 27–29]. A
widevariety ofmethodswereused tomeasure these subjective
symptoms, such as retrospective interviews [30], scale scoring
systems for subjective pre- and postoperative complaints
[31, 32] or subjective assessment by a skin therapist [33].
Masia et al. [34] and Chen et al. [35, 36] used two different,
standardised self-developed questionnaires on lymphedema-
related quality of life and reported an improvement in 100%of
their patients. The drawbacks were that no detailed results per
categorywere available on these scales, and neither were they
developed according to the three stages recommended for
patient reported outcome measures (PROM) nor validated
according to those standard stages. Therefore, no statistical
analysis on significance could be performed. Moreover, the
questionnaire used by Chen included only the physical func-
tion, which represents only one of the five domains of the
Lymph-ICF. In contrast, the Lymph-ICF is validated and
reproducible, allowing to systematically measure the changes
Table 1 The main study characteristics are presented. Patient char-
acteristics, type of cancer treatment and characteristics of the surgery
Characteristics Outcome
Patient characteristics
Number of patients 20
Female 20
Age 55.9 ± 4 years
BMI 25.1 [21–30] kg/m2
Time from lymphedema onset 6 [2–30] years




Lymph node dissection 100%
Mean number of Lymph nodes dissected 15.9
Mean number of positive lymph nodes 4.2
Surgery characteristics
Mean operating time 92 ± 8 min
Mean number of anastomosis 1.5
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resulting from surgery. The Lymph-ICF questionnaire gives a
score on five different domains, which may provide a wider
coverage of all the aspects related to lymphedema [25]. This
questionnaire can determine changes over time and may
provide useful and detailed information for long-term follow-
up. Furthermore, the used questionnaire is the only lym-
phedema-related questionnaire that uses a VAS score
answering model, which is more sensitive to subtle changes.
In addition, the existence of a different version of the same
questionnaire for lower limb lymphedema is interesting. Since
the impact of quality of life may differ depending on the
location of this disease, having two different versions might
allow for amore accurate assessment of the results.Althougha
questionnaire aims to objectify subjective symptoms, the
blinding of the patientsmight not be possible since it is an self-
completed questionnaire.
The current study demonstrated a high discontinuation
rate in the use of compressive stockings after surgery. This
might be explained by the release of arm heaviness as
indicated by the patients in the questionnaire. Patients
reported an immediately noticeable effect after the surgery.
This improvement was maintained during the follow-up
period, and patients felt that stockings were no longer
needed in order to control the volume of their arms. Even
though the use of stockings represented one of the most
deleterious factors for their quality of life, only few studies
have reported their results on stocking discontinuity. A
recent literature review performed by Basta et al. reported a
discontinuation of compression therapy of 56.3% in the
previous studies reporting on LVA in upper and lower limb
[12].
In contrast with the good rate of quality of life
improvement and stocking discontinuity, the volume
reduction did not show a proportional change in the present
study. A non-statistically significant reduction in excess
limb volume of 12.94% was observed in comparison with
previously reported rates of 42.9–64.6% [37–40]. This
difference in results might be explained by the fact that
80% (n = 16) of the patients in this study came to the
preoperative outpatient clinic visit wearing their stockings.
Within the group of patients who ceased to use stockings
after surgery, 50% (n = 10) showed an increase in arm
volume. The fact that all these patients wore stockings
during the preoperative measurements should be taken into
account. The other 50% (n = 10) of the patients did show a
volume reduction. Of these patients, only 15% (n = 5)
wore their stockings during preoperative measurements.
The improvement in quality of life and the high rate of
stockings cessation suggest that the LVA procedure may
be successful in reducing complaints related to BCRL by
preventing an accumulation of lymph fluid in the inter-
stitial tissue [14–17]. Objective measurements alone
might not be sufficient to assess the improvement in other
factors such as the sensation of heaviness, and unsta-
ble volume of the arm or pain. For this purpose, the use
of quality of life questionnaires should be encouraged to
properly assess the impact of this disease and its treat-
ments on patients.
Conclusions
LVA performed under local anaesthesia in patients with
early-stage BCRL resulted in a high rate of stocking dis-
continuation, contributing significantly to an improvement
in the quality of life of breast cancer survivors.
Fig. 1 The mean outcome on
the VAS score pre- and
postoperative according to the
Lymph-ICF preoperatively and
after 3, 6 and 12 months. *
indicates a statistical significant
decrease compared to the
preoperative measurement.
n number of patients who filled
in the questionnaire at that time
of follow-up
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